These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23467544)

  • 1. Suppression of endoplasmic reticulum stress-induced invasion and migration of breast cancer cells through the downregulation of heparanase.
    Li Y; Liu H; Huang YY; Pu LJ; Zhang XD; Jiang CC; Jiang ZW
    Int J Mol Med; 2013 May; 31(5):1234-42. PubMed ID: 23467544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of extracellular superoxide dismutase attenuates heparanase expression and inhibits breast carcinoma cell growth and invasion.
    Teoh ML; Fitzgerald MP; Oberley LW; Domann FE
    Cancer Res; 2009 Aug; 69(15):6355-63. PubMed ID: 19602586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tunicamycin-induced endoplasmic reticulum stress reduces in vitro subpopulation and invasion of CD44+/CD24- phenotype breast cancer stem cells.
    Nami B; Donmez H; Kocak N
    Exp Toxicol Pathol; 2016 Aug; 68(7):419-26. PubMed ID: 27350212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The heparanase inhibitor PG545 is a potent anti-lymphoma drug: Mode of action.
    Weissmann M; Bhattacharya U; Feld S; Hammond E; Ilan N; Vlodavsky I
    Matrix Biol; 2019 Apr; 77():58-72. PubMed ID: 30096360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Heparanase Expression Results in Suppression of Invasion, Migration and Adhesion Abilities of Bladder Cancer Cells.
    Tatsumi Y; Miyake M; Shimada K; Fujii T; Hori S; Morizawa Y; Nakai Y; Anai S; Tanaka N; Konishi N; Fujimoto K
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of cisplatin combined with heparanase inhibitor on proliferation and invasion of human nasopharyngeal carcinoma cells].
    Li Y; Liu H; Huang YY; Pu LJ; Zhang XD; Jiang ZW; Jiang CC
    Yao Xue Xue Bao; 2013 Apr; 48(4):609-14. PubMed ID: 23833953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
    Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
    J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparanase neutralizes the anticoagulation properties of heparin and low-molecular-weight heparin.
    Nasser NJ; Sarig G; Brenner B; Nevo E; Goldshmidt O; Zcharia E; Li JP; Vlodavsky I
    J Thromb Haemost; 2006 Mar; 4(3):560-5. PubMed ID: 16460439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design of a selective heparanase inhibitor as an antimetastatic agent.
    Ishida K; Hirai G; Murakami K; Teruya T; Simizu S; Sodeoka M; Osada H
    Mol Cancer Ther; 2004 Sep; 3(9):1069-77. PubMed ID: 15367701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of heparanase gene expression by estrogen in breast cancer.
    Elkin M; Cohen I; Zcharia E; Orgel A; Guatta-Rangini Z; Peretz T; Vlodavsky I; Kleinman HK
    Cancer Res; 2003 Dec; 63(24):8821-6. PubMed ID: 14695198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparan sulfate containing unsubstituted glucosamine residues: biosynthesis and heparanase-inhibitory activity.
    Nadanaka S; Purunomo E; Takeda N; Tamura J; Kitagawa H
    J Biol Chem; 2014 May; 289(22):15231-43. PubMed ID: 24753252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparanase promotes growth, angiogenesis and survival of primary breast tumors.
    Cohen I; Pappo O; Elkin M; San T; Bar-Shavit R; Hazan R; Peretz T; Vlodavsky I; Abramovitch R
    Int J Cancer; 2006 Apr; 118(7):1609-17. PubMed ID: 16217746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular properties and involvement of heparanase in cancer progression and mammary gland morphogenesis.
    Zcharia E; Metzger S; Chajek-Shaul T; Friedmann Y; Pappo O; Aviv A; Elkin M; Pecker I; Peretz T; Vlodavsky I
    J Mammary Gland Biol Neoplasia; 2001 Jul; 6(3):311-22. PubMed ID: 11547900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen induces heparanase expression in estrogen receptor-positive breast cancer.
    Cohen I; Maly B; Simon I; Meirovitz A; Pikarsky E; Zcharia E; Peretz T; Vlodavsky I; Elkin M
    Clin Cancer Res; 2007 Jul; 13(14):4069-77. PubMed ID: 17634531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparanase: Historical Aspects and Future Perspectives.
    Khanna M; Parish CR
    Adv Exp Med Biol; 2020; 1221():71-96. PubMed ID: 32274707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-1258 suppresses breast cancer brain metastasis by targeting heparanase.
    Zhang L; Sullivan PS; Goodman JC; Gunaratne PH; Marchetti D
    Cancer Res; 2011 Feb; 71(3):645-54. PubMed ID: 21266359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of OGT2115 inhibition of invasion and migration in KB oral cancer cells. Retracted.
    Shen S; Tang JX
    Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):55-60. PubMed ID: 28121356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arctigenin, a lignan from Arctium lappa L., inhibits metastasis of human breast cancer cells through the downregulation of MMP-2/-9 and heparanase in MDA-MB-231 cells.
    Lou C; Zhu Z; Zhao Y; Zhu R; Zhao H
    Oncol Rep; 2017 Jan; 37(1):179-184. PubMed ID: 27878294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latent heparanase facilitates VLA-4-mediated melanoma cell binding and emerges as a relevant target of heparin in the interference with metastatic progression.
    Gerber U; Hoß SG; Shteingauz A; Jüngel E; Jakubzig B; Ilan N; Blaheta R; Schlesinger M; Vlodavsky I; Bendas G
    Semin Thromb Hemost; 2015 Mar; 41(2):244-54. PubMed ID: 25682080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin enhances degradation of heparan sulfate in the extracellular matrix by tumor cell heparanase.
    Benezra M; Vlodavsky I; Bar-Shavit R
    Exp Cell Res; 1992 Jul; 201(1):208-15. PubMed ID: 1612123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.